Oncogenes and genetic aberration
Oncogenes and genetic aberration
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment
Transcriptional regulation of endothelial cell differentiation
Novel molecular insights on vertebrate genome stability maintenance
Stem cell generation of tumors and tissue physiology
Regulating the p53 pathway
Evolutionary view of the mechanism for immune diversity and genome instability
Targeted therapies for colorectal cancer
Targeting DNA repair in chemotherapy
Colon cancer microenvironments preventing invasion and metastasis
RAB5, master regulator of tumour, mesenchymal invasive programmes
Analysis of homologous recombination using the chicken B cell line, DT40